Articles Referencing CRME

Zacks.com

Cardiome Posts 4Q Profit - Analyst Blog

Cardiome Pharma Corp. ( CRME ) reported fourth quarter 2012 earnings of 13 cents per share as compared with the Zacks Consensus Estimate of a loss of 6 cents and the year-ago loss of 10... Read >>

Zacks.com

Cardiome Selects Quintiles - Analyst Blog

Cardiome Pharma Corp. ( CRME ) recently selected privately-held Quintiles for providing lifecycle safety and global regulatory affairs services for Brinavess (vernakalant intravenous). The... Read >>